Cargando…

Lipogenesis inhibitors: therapeutic opportunities and challenges

Fatty acids are essential for survival, acting as bioenergetic substrates, structural components and signalling molecules. Given their vital role, cells have evolved mechanisms to generate fatty acids from alternative carbon sources, through a process known as de novo lipogenesis (DNL). Despite the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batchuluun, Battsetseg, Pinkosky, Stephen L., Steinberg, Gregory R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758994/ https://www.ncbi.nlm.nih.gov/pubmed/35031766 http://dx.doi.org/10.1038/s41573-021-00367-2

Ejemplares similares

Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice
por: Desjardins, Eric M., et al.
Publicado: (2023)

Emerging therapeutic opportunities for integrin inhibitors
por: Slack, R. J., et al.
Publicado: (2021)

Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy
por: Silva, Valdenizia R., et al.
Publicado: (2020)

Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
por: Prescott, Jack A., et al.
Publicado: (2018)

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
por: Hammond, Suzan M, et al.
Publicado: (2021)

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
por: Pathania, Anup S., et al.
Publicado: (2021)

Bilirubin as a Therapeutic Molecule: Challenges and Opportunities
por: Adin, Christopher A.
Publicado: (2021)

Antioxidant Therapeutics in Parkinson’s Disease: Current Challenges and Opportunities
por: Duarte-Jurado, Ana Patricia, et al.
Publicado: (2021)

Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges
por: Gaule, Thembaninkosi G., et al.
Publicado: (2021)

Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities
por: Yang, Pingping, et al.
Publicado: (2023)

DNA methyltransferase inhibitor exposure–response: Challenges and opportunities
por: Kagan, Amanda B., et al.
Publicado: (2023)

Posttranslational control of lipogenesis in the tumor microenvironment
por: Zhu, Yahui, et al.
Publicado: (2022)

Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges
por: Lei, Xiaotian, et al.
Publicado: (2022)

Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
por: Li, De‐feng, et al.
Publicado: (2023)

Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities
por: Supuran, Claudiu T.
Publicado: (2022)

Phytomolecules Repurposed as Covid-19 Inhibitors: Opportunity and Challenges
por: Chandramouli, Vaishnavi, et al.
Publicado: (2021)

Challenges and Opportunities in Pharmacogenomics and Therapeutics
por: Kane, Michael D., et al.
Publicado: (2007)

PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities
por: Sim, Hao-Wen, et al.
Publicado: (2022)

The Challenge and Opportunity of NTRK Inhibitors in Non-Small Cell Lung Cancer
por: Qin, Haixia, et al.
Publicado: (2022)

Sex and Gender Differences in Neurodegenerative Diseases: Challenges for Therapeutic Opportunities
por: Bianco, Annalisa, et al.
Publicado: (2023)

Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
por: Rossino, Giacomo, et al.
Publicado: (2023)

Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities
por: Landré, Vivien, et al.
Publicado: (2014)

CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges
por: Arsenijevic, Tatjana, et al.
Publicado: (2023)

Challenges and Opportunities in the Management of Onychomycosis
por: Christenson, Julia K., et al.
Publicado: (2018)

Nutrigenomics and Beef Quality: A Review about Lipogenesis
por: Ladeira, Marcio M., et al.
Publicado: (2016)

Immune checkpoint inhibitors in lymphoma: challenges and opportunities
por: Hatic, Haris, et al.
Publicado: (2021)

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology
por: Roulston, Anne, et al.
Publicado: (2015)

Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges
por: Poh, Ashleigh R., et al.
Publicado: (2021)

Radiation-induced senescence: therapeutic opportunities
por: Kim, Jae Ho, et al.
Publicado: (2023)

Endothelial Senescence and the Chronic Vascular Diseases: Challenges and Therapeutic Opportunities in Atherosclerosis
por: Ramírez, Rafael, et al.
Publicado: (2022)

Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
por: Jain, Aditi, et al.
Publicado: (2021)

The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint
por: Momin, Mohammad Yahya, et al.
Publicado: (2021)

Ethical challenges and opportunities in the development and approval of novel therapeutics for rare diseases
por: Djordjevic, Djurdja, et al.
Publicado: (2023)

Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
por: Brar, Harpinder K., et al.
Publicado: (2022)

Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges
por: Regzedmaa, Orgilmaa, et al.
Publicado: (2019)

Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics
por: Ruscetta, Vanessa M., et al.
Publicado: (2023)

Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities
por: Frustaci, Anna Maria, et al.
Publicado: (2023)

SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges
por: Coke, Christopher J., et al.
Publicado: (2021)

Expanding Roles of De Novo Lipogenesis in Breast Cancer
por: Simeone, Pasquale, et al.
Publicado: (2021)

Molecular Regulation of Lipogenesis, Adipogenesis and Fat Deposition in Chicken
por: Nematbakhsh, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_04ud88pl2lb83ghjc3f903jd06